[A16-13] Empagliflozin/metformin - Benefit assessment according to §35a Social Code Book V
Last updated 01.06.2016
Project no.:
A16-13
Commission:
Commission awarded on 29.02.2016 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Digestion, metabolism and hormones
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A16-47 | Empagliflozin/metformin - Addendum to Commission A16-13 | Commission completed |
Federal Joint Committee (G-BA)
2016-09-01 A G-BA decision was published.